Market Overview

Johnson & Johnson Under Selling Pressure

Related JNJ
Goldman Says These 25 Healthcare Stocks Are Immune To The Election
Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage Daily Round Up 10/25/16: CREE, MCC, REED, ERC (Seeking Alpha)

Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.

Johnson & Johnson (NYSE: JNJ) shares are trading lower by $2.22 at $98.16 in Thursday's session. The newswires have not identified any particular reason for the decline.

The latest news item reported was on Tuesday, when Benzinga reported unconfirmed chatter that Goldman Sachs was exploring a breakup into three separate companies.

The issue has not reacted favorable to earnings beat of $0.01 ($1.27 vs. $1.26) announced on January 20. Perhaps the Street is concerned with its first revenue miss ($18.25B vs. EST $18.56) in its last eight quarters.

After clinging to the $100,00 level, posting a double close on Tuesday ($100.35) and Wednesday ($100.38), it failed to maintain that important level after reaching $100.54. Off the open it has declined to $97.15.

That level coincides with an October 17 low of $97.31.

Since reaching that depressed level, it is has been attempting to regain the $98.00 handle and has reached the mid-range of that handle on its rebound.

Posted-In: Pre-market otulookTechnicals Movers & Shakers Intraday Update Movers Trading Ideas General


Related Articles (JNJ)

View Comments and Join the Discussion!